Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tegoprazan

🥰Excellent
Catalog No. T17030Cas No. 942195-55-3

Tegoprazan is an orally active, highly selective gastric H+/K+-ATPase inhibitor that controls gastric acid secretion and motility, with an IC50 of 0.29-0.52 μM for porcine, canine, and human H+/K+-ATPase in vitro.

Tegoprazan

Tegoprazan

🥰Excellent
Purity: 98.22%
Catalog No. T17030Cas No. 942195-55-3
Tegoprazan is an orally active, highly selective gastric H+/K+-ATPase inhibitor that controls gastric acid secretion and motility, with an IC50 of 0.29-0.52 μM for porcine, canine, and human H+/K+-ATPase in vitro.
Pack SizePriceAvailabilityQuantity
1 mg$48In Stock
5 mg$123In Stock
10 mg$189In Stock
25 mg$313In Stock
50 mg$413In Stock
100 mg$538In Stock
200 mg$766In Stock
1 mL x 10 mM (in DMSO)$135In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tegoprazan"

Select Batch
Purity:98.22%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tegoprazan is an orally active, highly selective gastric H+/K+-ATPase inhibitor that controls gastric acid secretion and motility, with an IC50 of 0.29-0.52 μM for porcine, canine, and human H+/K+-ATPase in vitro.
Targets&IC50
H+, K+-ATPase:0.29-0.52 μM
In vitro
METHODS: BMM cells were cultured with Tegoprazan (CJ-12420) (0, 0.0005, 0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1, 10, 100 and 1000 μg/mL, 24 hours) to investigate its effects on BMM cytotoxicity and nitric oxide (NO) production.
RESULTS When the concentration of Tegoprazan was 0.5, 1, 10 and 100 μg/mL, the cell viability exceeded 80%; when the concentration was 1000 μg/mL, the cell viability was less than 80%; 100 μg/mL of Tegoprazan could significantly inhibit NO production in BMM cells. [3]
In vivo
METHODS: Tegoprazan (CJ-12420) (3, 10 mg/kg, oral, 5 days) was used to treat pylorus-ligated rats, and the effects of Tegoprazan and esomeprazole on gastric acid secretion in pylorus-ligated rats were observed.
RESULTS The gastric fundus pH values ​​of 3 mg/kg Tegoprazan were 4.13 and 4.34, respectively, and the gastric fundus pH values ​​of 10 mg/kg Tegoprazan were 6.86 and 6.63, respectively. Tegoprazan can completely inhibit gastric acid secretion. [3]
Chemical Properties
Molecular Weight387.38
FormulaC20H19F2N3O3
Cas No.942195-55-3
SmilesCN(C)C(=O)c1cc(O[C@H]2CCOc3cc(F)cc(F)c23)c2[nH]c(C)nc2c1
Relative Density.1.371 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 22.5 mg/mL (58.08 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5814 mL12.9072 mL25.8144 mL129.0722 mL
5 mM0.5163 mL2.5814 mL5.1629 mL25.8144 mL
10 mM0.2581 mL1.2907 mL2.5814 mL12.9072 mL
20 mM0.1291 mL0.6454 mL1.2907 mL6.4536 mL
50 mM0.0516 mL0.2581 mL0.5163 mL2.5814 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tegoprazan | purchase Tegoprazan | Tegoprazan cost | order Tegoprazan | Tegoprazan chemical structure | Tegoprazan in vivo | Tegoprazan in vitro | Tegoprazan formula | Tegoprazan molecular weight